Afuco™ Anti-IGF1R ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-209) (CAT#: AFC-TAB-209)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IGF1 Receptor. It is a monoclonal antibody and an antineoplastic by Schering-Plough. It binds to CD221, the insulin-like growth factor 1 receptor.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • FuncS, IF, Neut, ELISA, FC, IP
  • Conjugate
  • Unconjugated
  • Generic Name
  • Robatumumab
  • Related Disease
  • Blood cancers

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • IGF1R; insulin-like growth factor 1 receptor; CD221; IGFIR; IGFR; JTK13; MGC18216; IGF-I receptor; soluble IGF1R variant 1; soluble IGF1R variant 2; insulin-like growth factor I receptor;

Related Resources

  • Biosimilar Overview
  • Related Signaling Pathways
  • Related Diseases
Please refer to Robatumumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Robatumumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Robatumumab"

DrugMonitor™ Anti-Robatumumab Antibody (VS-1224-YC1028)
Robatumumab is a monoclonal antibody with antineoplastic properties, studied in trials for conditions like osteosarcoma, Ewing's sarcoma, and peripheral neuroectodermal tumor. The DrugMonitor™ Anti-Robatumumab Antibody (VS-1224-YC1028) is an anti-drug antibody (ADA) against Robatumumab. This drug-based antibody is raised in mice immunized with the Robatumumab. The anti-Robatumumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Robatumumab in samples.

See other products for "IGF1R"

Select a product category from the dropdown menu below to view related products.
Please select product type
Single Domain Antibody Products Immunotoxin Products ADCC Enhanced Antibody Products Humanized Antibody Products Chimeric Antibody Products Mouse Antibody Products Human Antibody Products Chicken IgY Antibody Products Neutralizing Antibody Products Blocking Antibody Products Rabbit Monoclonal Antibody Products IgG Antibody Products Neuroscience Antibody Products Fab Antibody Products ScFv Antibody Products Antibody Magnetic Beads ScFv-Fc Chimera Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-209. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare